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Background: Early studies suggested that TR4 nuclear receptor might play important roles in the skeletal
development, yet its detailed mechanism remains unclear.
Methods: We generated TR4 knockout mice and compared skeletal development with their wild type littermates.
Primary bone marrow cells were cultured and we assayed bone differentiation by alkaline phosphatase and alizarin
red staining. Primary calvaria were cultured and osteoblastic marker genes were detected by quantitative PCR.
Luciferase reporter assays, chromatin immunoprecipitation (ChIP) assays, and electrophoretic mobility shift assays
(EMSA) were performed to demonstrate TR4 can directly regulate bone differentiation marker osteocalcin.
Results: We first found mice lacking TR4 might develop osteoporosis. We then found that osteoblast progenitor cells
isolated from bone marrow of TR4 knockout mice displayed reduced osteoblast differentiation capacity and
calcification. Osteoblast primary cultures from TR4 knockout mice calvaria also showed higher proliferation rates
indicating lower osteoblast differentiation ability in mice after loss of TR4. Mechanism dissection found the expression
of osteoblast markers genes, such as ALP, type I collagen alpha 1, osteocalcin, PTH, and PTHR was dramatically reduced
in osteoblasts from TR4 knockout mice as compared to those from TR4 wild type mice. In vitro cell line studies with
luciferase reporter assay, ChIP assay, and EMSA further demonstrated TR4 could bind directly to the promoter region of
osteocalcin gene and induce its gene expression at the transcriptional level in a dose dependent manner.
Conclusions: Together, these results demonstrate TR4 may function as a novel transcriptional factor to play
pathophysiological roles in maintaining normal osteoblast activity during the bone development and remodeling, and
disruption of TR4 function may result in multiple skeletal abnormalities.
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The TR4 nuclear receptor belongs to the nuclear receptor
superfamily, which is comprised of transcription factors that
are related by sequence and structure [1]. As transcription
factors, nuclear receptors control the expression of target
genes and thereby direct developmental, physiological, and
behavioral responses from the cellular level to that of the
whole organism. TR4 is closely related to the TR2, retinoid
X receptor, COUP-TF, and HNF4 in sequence and structure
[2], and all of them bind to AGGTCA DNA sequence motifs* Correspondence: chang@urmc.rochester.edu
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reproduction in any medium, provided the orin direct repeat (DR) orientation, with variable spacing, in
the promoters of their target genes [1,3-6]. Via knocking out
TR4 (TR4−/−), a complex set of phenotypic abnormalities
were found to exist in the TR4−/− mouse, including signifi-
cant growth retardation [7], defects in female reproductive
function [8] and maternal behavior [7], impaired cerebella
function [9,10], reduced sperm production [11], and reduced
myelination [12], as well as abnormalities in glucose [13],
lipid metabolism [14], and foam cell formation [15].
In this study, we reported that TR4 is involved in regula-
tion of osteoblast activity via regulating osteocalcin expres-
sion. TR4 might represent a novel transcriptional factor
involved in the bone remodeling network and provide a po-
tential linkage to the pathogenesis of osteoporosis in human
disease.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Mouse studies
All animal procedures were approved by the Animal
Care and Use Committee of the University of Rochester.
TR4−/− mice used in this study were generated from het-
erozygous breeding pairs provided by Lexicon Genetics
and genotyped as previously described [16].Cell culture
Bone marrow cells were isolated from 10 weeks old TR4
wild type (TR4+/+) and TR4−/− mice. Cells were cultured in
2 mL of a modified essential medium (α-MEM) containing
10% fetal bovine serum (FBS) at 5x106 cells/well in 6-well
plates. After 7 days in culture, the media was replaced with
media containing 10 mM β-glycerophosphate and 50 mg/
mL ascorbic acid. This media was changed every 2 days
thereafter. On day 21 after plating, cells were fixed for alka-
line phosphatase (ALP) and alizarin red staining or harvested
for mRNA isolation using the RNeasy Mini Kit (Qiagen).
Mouse calvaria cells were obtained from neonatal mice 2–
4 days after birth using sequential collagenease digestion.














Figure 1 Skeletal abnormalities in TR4−/− mice. A: Reduced bone miner
pairs of 6 months old TR4−/− male and female mice, respectively. The avera
volume in TR4−/− long bone (upper panel) and spinal column (L-spine, low
legs and lumbar-spines. M: bone marrow; T: trabeculae; C: cortex. Accumul
more fat accumulation in TR4−/− mice bone marrow. C: Continuing reduce
Osteoarthritis in TR4−/− mice. 6 months old TR4−/− knee joint shows signs o1 mg/mL collagenase. Cells were collected by centrifugation,
and cultured in proliferation media (DMEM with 20% FBS).
Calvaria cells were cultured until 80% confluence and prolif-
eration media was replaced by differentiation media (α-
MEM containing 10% FCS, 2 mmol/L glutamine, 50 mg/mL
ascorbic acid, and 10 mmol/L b-glycerol phosphate).Real-time PCR
Total RNA was isolated from TR4−/− and TR4+/+ mice cal-
varia cultures using TRIzol Reagent (Invitrogen). The rela-
tive abundance of target mRNA was quantified relative to
the control β-actin gene expression from the same reaction.
Real-time PCR quantification amplifications of reverse-
transcribed first strand DNA samples were performed using
the iCycler iQ PCR cycler (Bio-Rad). Relative quantification
of PCR products were based on value differences between
the target and β-actin control using the 2ΔΔCT method.The electrophoretic mobility shift assay (EMSA) &
chromatin immunoprecipitation (ChIP) assay
TR4 protein for EMSA was transcribed and translated in
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Figure 2 TR4−/− bone marrow cultures have reduced osteoblast differentiation. Bone marrow cells were isolated from 10 weeks old TR4−/−
and control TR4+/+ mice. Cells were cultured in 2 mL α-MEM containing 10% FBS at 5x106 cells/well in 6-well plates. After 7 days, the media was
replaced with media containing β-glycerophosphate and ascorbic acid to induce osteoblast differentiation. Colonies were stained on day 21 after
plating by alkaline phosphatase (A) and alizarin red (B). The assays were performed in triplicate.
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presence or absence of a mouse anti-TR4 monoclonal anti-
body. The protein/DNA complexes were analyzed on a 5%
native polyacrylamide gel. The results were visualized by
autoradiography (Storm PhosphorImaging System, Amer-
sham Pharmacia).
ChIP assays were performed in MC3T3 cells. Immu-
noprecipitations were performed at 4°C overnight, with
2 μg monoclonal antibody.
Bone tissue preparation
The femurs were collected and excess muscle and soft
tissues were excised. The bone specimens were fixed in
10% neutral buffered formalin. The specimens were dec-
alcified for 21 days in 14% EDTA (pH 7.2), embedded in
paraffin, and sectioned at thickness of 3 μm. The sec-
tions were stained as described previously [17].Results
Mice lacking TR4 develop skeletal abnormalities
Knockout of TR4 in mice results in growth retardation
with reduction of circulating growth hormone [16]. One of
the possible mechanisms is through regulation of skeletal
growth. However, skeletal abnormalities can result from a
direct effect on bone formation or remodeling. Clinically,
the decreased bone mass observed in age-related osteopor-
osis is often accompanied by increased marrow adipose tis-
sue. We found mice lacking TR4 might develop
osteoporosis. As shown in Figure 1A, DEXA scan of TR4+/+
and TR4−/− mice at 6 months of age revealed a significant
reduction in bone mineral density in both male and female
mice. Bone histology of TR4−/− trabecular bone showed
significant increased marrow adipocyte deposits
(Figure 1B, upper panel, arrows). In addition, reduced bone
volume was found in the spinal column (L-spine) of the
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lower panel). Reduced trabecular bone volume and
increased adipocyte deposits were also found in 9 months
old and over a year old TR4−/− mice (Figure 1C). Interest-
ingly, a few TR4−/− mice at age of 6 months also started to
develop signs of osteoarthritis with increasing superficial
zone cells and disruption of articular surface. (Figure 1D).
Together, results from Figure 1A-D suggest loss of TR4
may lead to the development of skeletal abnormalities.Reduced osteoblast differentiation in TR4−/− mice
All above observed skeletal abnormal phenotypes suggest
that the TR4−/− mice may develop accelerated bone loss,
which is similar to human osteoporosis. To determine
whether TR4 has a direct impact on the osteoblastic activ-
ity, bone marrow progenitor cells extracted from TR4−/−
and TR4+/+ mice were isolated and placed in culture for
colony formation assays. After 7 days, osteogenic media






















Figure 3 Characterization of primary calvaria cultures from TR4−/− vs.
calvaria cultures of TR4−/− and TR4+/+ pups by 3 H-thymidine incorporation
number seeding density. B: Quantification of osteoblastic marker gene exp
TR4−/− and TR4+/+ mice, and converted to first strand cDNA, and subjected
as compared to TR4+/+ mice, were calculated. C: The serum levels of osteoadded to the cultures. ALP and alizarin red staining was
performed, and ALP staining showed fewer colonies
formed with reduced ALP density present in the TR4−/−
bone marrow cells as compared to TR4+/+ littermates
(Figure 2A). Similarly, alizarin red staining was decreased
in the TR4−/− bone marrow cells compared with TR4+/+
control (Figure 2B). Together, results from Figure 2A-B
suggests TR4 can regulate bone differentiation.Reduction of osteoblastic differentiation and associated
genes in calvaria from TR4−/− mice
To further confirm TR4 roles in osteoblast differenti-
ation, primary osteoblasts from 2–4 day old TR4−/− mice vs.
TR4+/+ mice calvaria were isolated and cultured. Cell prolif-
eration rates were compared with different seeding densities
(from 2x104-1x105 cells), and results showed that calvaria
cells from TR4−/− mice had higher proliferation rates than
those from TR4+/+ mice, indicating lower osteoblast differ-
















TR4+/+ mice. A: Proliferation rate was compared between primary
assay. The 20 K, 50 K, and 100 K numbers represent different cell
ression. Total RNA were harvested from the primary calvaria cells of
to q-PCR. The relative expression fold of the genes from TR4−/− mice,
calcin from TR4−/− and TR4+/+ mice were determined by ELISA.
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to determine the expression of genes associated with osteo-
blast activity. As shown in Figure 3B, all the expression levels
of osteoblast marker genes, including PTH, PTHR, osteocal-
cin, and type I collagen alpha 1 were found to be dramatic-
ally reduced in osteoblasts from TR4−/− mice as compared
to those from TR4+/+ mice. This reduction of osteoblastic
gene expression also reflected undetectable serum concen-
trations of osteocalcin, a bio-marker for osteoblast activity,
found in TR4−/− mice (Figure 3C), suggesting TR4 may be
able to regulate bone differentiation through those differenti-
ation markers.
TR4 modulates osteocalcin gene at transcriptional level
To further dissect the molecular mechanism by which TR4
can modulate those osteoblast marker genes, we focused on
the osteocalcin gene regulation, since osteocalcin is secretedOC-Luc/CV
TR4 - + ++






















Figure 4 TR4 transcriptionally regulates osteocalcin expression. A: Ov
pCMX-TR4 (1 and 2 μg, marked as + and ++, respectively) and the positive
luciferase reporter assay (OC-Luc/CV). B: Overexpressing TR4 mutants (TR44
of TR4 by siTR4 reduces osteocalcin promoter activity. Retro-siTR4 was infec
assay. D: Mutation of osteocalcin promoter diminishes promoter activity. A
with TR4, and followed by a reporter gene assay. All the experiments wereonly by osteoblasts and thought to play an important role in
the regulation of osteoblastic activity in bone mineralization
and calcium ion homeostasis [18,19]. As a transcriptional
factor, TR4 is known to bind to AGGTCA-like DR motif
located in the targeted gene’s promoter region to regulate its
expression. It has been reported that the 5′-promoter region
of the osteocalcin gene contains the DR3 motif that can be
bound and regulated by vitamin D receptor (VDR). This
DR3 motif is highly conserved among species and the
sequences are very similar among rat, mouse, and human
promoters [20,21]. Since TR4 and VDR share the same re-
sponse element [5], it is possible that TR4 can also bind and
regulate osteocalcin at the transcriptional level. As shown in
Figure 4A, TR4 induced osteocalcin promoter luciferase
(OC-Luc) activity in a dose-dependent manner. Cbfa, a
known osteocalcin transcriptional factor [22], was used as a
positive control.OC-Luc/CV
TR4 - ++ TR4ΔN TR4ΔC
B
OC-Luc/CV OCm-Luc/CV
TR4 - + - +
D
erexpression of TR4 promotes OC-Luc activity. Increasing amounts of
control pCMX-cbfa were transfected into CV-1 cells, followed by
N or TR44C) diminishes osteocalcin promoter activity. C: Knockdown
ted into OC-Luc transfected CV-1 cells, followed by a reporter gene
mutation of TR4RE in osteocalcin (OCm-Luc/CV) was co-transfected
repeated three times independently.
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terminals of TR4 (TR44N and TR44C, respectively)
resulted in loss of the TR4 ability to transactivate OC-Luc
(Figure 4B), suggesting the full-length of TR4 is required
for this regulation. This conclusion was further confirmed
showing TR4-mediated osteocalcin promoter transcrip-
tional activation was reduced in the TR4-siRNA knock-
down cells in a dose dependent manner (Figure 4C).
Importantly, as the third G within the DR motif is important
for TR4 binding, we therefore mutated this position from
GGGTGAatgAGGACA to GGATGAatgAGTACA and as
expected, we found mutated TR4RE in OC-Luc (OCm-Luc)
was no longer able to transactivate luciferase activity
(Figure 4D).
Together, results from Figure 4A-D suggested that
TR4 modulated bone formation via regulating osteocal-
cin gene expression at the transcriptional level.TR4 binds to the regulatory sequence of osteocalcin gene
in vitro and in vivo
To further prove TR4 can bind directly to this DR3 DNA
fragment, the TR4 response element (TR4RE) that is
located at −465 to −437 of the osteocalcin promoter, we
performed ChIP assay. As shown in Figure 5A, TR4 anti-
body, but not IgG control, could pull-down the DNA-
protein complex containing the DR3 that could be ampli-
fied by the specific primers covering that region.
To further test the TR4-TR4RE interaction in vitro,
EMSA was applied. As shown in Figure 5B, TR4 can
form a complex with TR4RE, and this TR4-TR4RE can
be super shifted by adding TR4 antibody (lane 2) [4].
The specific TR4-DNA-protein complex was further





Figure 5 TR4 binds to TR4RE in osteocalcin promoter. A: The binding o
Anti-TR4 antibody was used to pull-down the DNA-protein complex, and b
TR4RE. B: EMSA. TR4 proteins were translated by TNT rabbit reticular lysate
32P, and TR4 antibody was used for the super shift (lane 2). 100 x cold com
applied.not mutant TR4RE (TR4REm) (lane 4 and 5), suggesting
TR4 can physically bind to osteocalcin promoter region
to transcribe its expression.Discussion
We found that TR4 directly influences osteoblast activity
with reduced osteoblast differentiation found in bone mar-
row progenitor cells isolated from TR4−/− mice as com-
pared to TR4+/+ mice. This reduction of bone marrow
progenitor cells differentiation could then contribute to
osteoporosis developed in their later life. Our data are in
agreement with the critical role of bone marrow progeni-
tor cells in the senile osteoporosis where depletion and/or
inhibition of bone marrow progenitor cells differentiation
and activation could cause osteoporosis. TR4 represents a
novel factor that controls differentiation of bone marrow
progenitor cells allowing for osteoblast formation. And
the depletion of TR4 in mice results in premature aging
accompanied with osteoporosis in both genders. TR4−/−
mice display a significant adipocyte accumulation in their
trabecular bones, indicating that blocking TR4 function
can also alter the balance between adipogenesis and osteo-
genesis, and that bone formation is inhibited. These find-
ings make TR4 a candidate gene to monitor bone activity.
TR4 transcript levels did not alter when undifferenti-
ated embryonic stem cells were induced into adipocytes
and osteoblasts [23], suggesting that the environmental/
exogenous factors that control TR4 activity might be
critical for controlling the bone marrow progenitor cells
activity to affect osteoblast differentiation. Therefore,
identifying its upstream modulator(s) offers novel thera-
peutic and/or preventive approaches to target senile
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f TR4 to TR4RE (DR3) in osteocalcin was demonstrated by ChIP assay.
inding sequence was amplified by the specific primers that cover the
and applied to the gel shift assay. The probe (TR4RE) was labeled with
petition with wild type TR4RE (lane 3), or TR4REm (lane 4, 5) were
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mote osteogenesis, such that bone formation can be
enhanced [24]. Since both TR4 and PPAR gamma are
members of the nuclear receptor superfamily and share
the similar regulatory DNA response elements and some
upstream modulator(s), it will be of interest to dissect
the activity/specificity of both receptors in the process of
early bone marrow progenitor cells differentiation that
might have a great impact on the osteoblast activity.
Conclusions
Together, these results demonstrate TR4 may function
as a novel transcriptional factor to play its pathophysio-
logical roles in maintaining normal osteoblast activity
during the bone development and remodeling, and dis-
ruption of TR4 function may result in multiple skeletal
abnormalities.
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